Rajesh C. Shrotriya
2017
In 2017, Rajesh C. Shrotriya earned a total compensation of $8.9M as Former Chairman and Chief Executive Officer at Spectrum Pharmaceuticals, a 222% increase compared to previous year.
Compensation breakdown
| Bonus | $863,316 |
|---|---|
| Option Awards | $686,601 |
| Salary | $905,625 |
| Stock Awards | $1,322,297 |
| Other | $5,111,103 |
| Total | $8,888,942 |
Shrotriya received $5.1M in other compensation, accounting for 57% of the total pay in 2017.
Shrotriya also received $863.3K in bonus, $686.6K in option awards, $905.6K in salary and $1.3M in stock awards.
Rankings
In 2017, Rajesh C. Shrotriya's compensation ranked 777th out of 14,666 executives tracked by ExecPay. In other words, Shrotriya earned more than 94.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 777 out of 14,666 | 95th |
Division Manufacturing | 259 out of 5,768 | 96th |
Major group Chemicals And Allied Products | 62 out of 2,074 | 97th |
Industry group Drugs | 43 out of 1,730 | 98th |
Industry Pharmaceutical Preparations | 36 out of 1,329 | 97th |
Source: SEC filing on May 7, 2018.
Shrotriya's colleagues
We found three more compensation records of executives who worked with Rajesh C. Shrotriya at Spectrum Pharmaceuticals in 2017.